Ģirts Šķenders
Ģirts Šķenders publishes mostly in Epidemiology, Infectious Diseases and Surgery, on topics such as Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis and Pneumonia and Respiratory Infections.
- World rank
- #2,116,754 of 7,710,434 ranked researchers
- Rank in Latvia
- #271 of 4,070
- Works
- 36
- Citations
- 1.7k
- Citations per work
- 46.3
What does Ģirts Šķenders research?
Ģirts Šķenders's work is mostly in Medicine (72%), Biochemistry, Genetics and Molecular Biology (10%), Immunology and Microbiology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2671.9%
- Medicine2671.9%
- Everything else615.5%
- Life Sciences512.6%
- 1Epidemiology30% of their works
- 2Infectious Diseases30% of their works
- 3Surgery12% of their works
- 4Molecular Biology6% of their works
- 5Molecular Medicine4% of their works
- 6Immunology3% of their works
Research topics
- Tuberculosis Research and Epidemiology
- Mycobacterium research and diagnosis
- Pneumonia and Respiratory Infections
- Helicobacter pylori-related gastroenterology studies
- Antibiotic Resistance in Bacteria
- Clostridium difficile and Clostridium perfringens research
- Diagnosis and treatment of tuberculosis
- Gut microbiota and health
Which keywords describe Ģirts Šķenders's research?
The keywords of their largest research topics: Epidemiology, Diagnosis, Treatment, Antibiotic Resistance, Mycobacterium tuberculosis, Tuberculosis, Mycobacterium avium and Nontuberculous Mycobacteria.
- Gut Microbiota
- Fecal Microbiota Transplantation
- Diagnostic Challenges
- Abdominal Tuberculosis
- Gastric Cancer
- Community-Acquired Pneumonia
- Nontuberculous Mycobacteria
- Tuberculosis
- Antibiotic Resistance
- Diagnosis
- Epidemiology
- Treatment
- Mycobacterium tuberculosis
- Mycobacterium avium
- Clinical Practice Guidelines
- Pneumococcal Conjugate Vaccine
- Helicobacter pylori
- Antibiotic-Associated Diarrhea
- ESKAPE Pathogens
- Multidrug-Resistant Bacteria
- Microbial Communities
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Epidemiology544 topics
- Diagnosis412 topics
- Treatment412 topics
- Antibiotic Resistance253 topics
- Mycobacterium tuberculosis251 topic
- Tuberculosis251 topic
- Mycobacterium avium161 topic
- Nontuberculous Mycobacteria161 topic
- Clinical Practice Guidelines132 topics
- Community-Acquired Pneumonia91 topic
- Pneumococcal Conjugate Vaccine91 topic
- Gastric Cancer51 topic
- Helicobacter pylori51 topic
- Abdominal Tuberculosis41 topic
- Antibiotic-Associated Diarrhea41 topic
- Diagnostic Challenges41 topic
- ESKAPE Pathogens41 topic
- Fecal Microbiota Transplantation41 topic
- Multidrug-Resistant Bacteria41 topic
- Gut Microbiota31 topic
- Microbial Communities31 topic
Where does Ģirts Šķenders work?
Ģirts Šķenders's main affiliation in the publication record is Riga East University Hospital, Latvia.
How many publications and citations does Ģirts Šķenders have?
OpenAlex counts 36 works and 1,666 citations for Ģirts Šķenders, an h-index of 17, ranking #2,116,754 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ģirts Šķenders. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.